CENTENE CORPORATION
CENTENE CORPORATION (CNC) has a dated report snapshot, but its current priced-in claim is temporarily suppressed because the live engine record is unavailable or has changed.
• Centene is the largest Medicaid managed-care insurer in the country, with Medicaid roughly 58% of its mix alongside marketplace and Medicare books, so its fortunes track government healthcare budgets more than the broader economy. • The defining recent fact is the turnaround: after a loss-making stretch in 2025, the company swung back to $1.5 billion of net earnings in the first quarter of 2026 as Medicaid margins began to recover [Source: Q1 2026 results]. • The risk to watch is Medicaid rate
Is CNC overvalued? See what's priced in →
838 institutional managers reported holding CNC in 13F filings for the quarter ended 2026-03-31. Together they hold about 95% of the company; the top 10 hold 44%. 86 opened new positions that quarter. Held by Vanguard Group, BlackRock, AQR Capital, among others. On the short side, 14.8M shares were sold short as of the 2026-06-15 count, about 3% of shares outstanding (2.8 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
CNC has cut its share count 15.6% over the past five years, spending $8.65B on repurchases. It pays no dividend. Cash returned over the past three years: $4.46B in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at CNC over the trailing three years: 2024: 7 buys totaling $3.27M; 2025: 2 buys totaling $739k. 18 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
CNC's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-07-29 | -5.4% | +4.1% |
| 2023-10-25 | -3.0% | +6.9% |
| 2024-02-21 | +1.1% | -3.8% |
| 2024-04-27 | -2.2% | -10.4% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
CNC's latest 8-K filings: 2026-06-22 (items 5.02, 7.01, 9.01); 2026-05-15 (items 5.02, 5.07); 2026-04-28 (items 2.02, 9.01); 2026-03-24 (items 5.02); 2026-03-10 (items 7.01, 8.01).
Item codes are the SEC's own classification of what each report discloses. Nothing here is investment advice.
Last analyzed: June 27, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.